Healthcare provider profile · identity verified

Celia S Brinker, NP

Nurse Practitioner · HENDERSON, NC · NPI 1528258852

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	456	113
Rosuvastatin Calcium	Rosuvastatin Calcium	331	92
Hydrochlorothiazide	Hydrochlorothiazide	329	86
Atorvastatin Calcium	Atorvastatin Calcium	306	88
Omeprazole	Omeprazole	284	77
Lisinopril	Lisinopril	281	74
Metformin Hcl	Metformin Hcl	270	72
Levothyroxine Sodium	Levothyroxine Sodium	258	58
Losartan Potassium	Losartan Potassium	240	65
Simvastatin	Simvastatin	239	56
Gabapentin	Gabapentin	227	53
Pantoprazole Sodium	Pantoprazole Sodium	169	46
Potassium Chloride	Potassium Chloride	153	42
Sertraline Hcl	Sertraline Hcl	127	28
Metoprolol Succinate	Metoprolol Succinate	122	34
Metoprolol Tartrate	Metoprolol Tartrate	115	31
Lorazepam	Lorazepam	111	22
Furosemide	Furosemide	102	32
Zolpidem Tartrate	Zolpidem Tartrate	100	16
Duloxetine Hcl	Duloxetine Hcl	93	19
Albuterol Sulfate Hfa	Albuterol Sulfate	90	32
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	86	19
Pravastatin Sodium	Pravastatin Sodium	85	24
Escitalopram Oxalate	Escitalopram Oxalate	83	23
Tramadol Hcl	Tramadol Hcl	80	15
Trazodone Hcl	Trazodone Hcl	77	17
Carvedilol	Carvedilol	70	18
Alprazolam	Alprazolam	66	12
Ezetimibe	Ezetimibe	66	15
Fluticasone Propionate	Fluticasone Propionate	66	24
Tamsulosin Hcl	Tamsulosin Hcl	66	17
Allopurinol	Allopurinol	65	19
Spironolactone	Spironolactone	63	15
Eliquis	Apixaban	62	14
Fenofibrate	Fenofibrate Nanocrystallized	62	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	55	14
Glipizide Er	Glipizide	53	16
Ozempic	Semaglutide	52	11
Alendronate Sodium	Alendronate Sodium	51	12
Clopidogrel	Clopidogrel Bisulfate	50	16
Glimepiride	Glimepiride	49	15
Meloxicam	Meloxicam	48	13
Mirtazapine	Mirtazapine	47	suppressed
Clonidine Hcl	Clonidine Hcl	45	suppressed
Prednisone	Prednisone	45	43
Citalopram Hbr	Citalopram Hydrobromide	44	15
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	43	11
Jardiance	Empagliflozin	42	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	40	suppressed
Benazepril Hcl	Benazepril Hcl	39	11
Montelukast Sodium	Montelukast Sodium	39	11
Xarelto	Rivaroxaban	39	suppressed
Cephalexin	Cephalexin	38	32
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	38	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	37	suppressed
Metformin Hcl Er	Metformin Hcl	37	suppressed
Atenolol	Atenolol	36	suppressed
Famotidine	Famotidine	36	suppressed
Ropinirole Hcl	Ropinirole Hcl	36	suppressed
Ventolin Hfa	Albuterol Sulfate	36	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	35	11
Fluoxetine Hcl	Fluoxetine Hcl	35	suppressed
Bupropion Xl	Bupropion Hcl	34	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	33	31
Doxepin Hcl	Doxepin Hcl	33	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	33	suppressed
Tizanidine Hcl	Tizanidine Hcl	33	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	33	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	31	suppressed
Diazepam	Diazepam	31	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	29	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	28	suppressed
Valacyclovir	Valacyclovir Hcl	28	suppressed
Clonazepam	Clonazepam	27	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	26	24
Triamcinolone Acetonide	Triamcinolone Acetonide	26	15
Metoclopramide Hcl	Metoclopramide Hcl	24	suppressed
Finasteride	Finasteride	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	22
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	23	suppressed
Topiramate	Topiramate	23	suppressed
Estradiol	Estradiol	22	suppressed
Ramipril	Ramipril	22	suppressed
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Fluconazole	Fluconazole	19	14
Tresiba Flextouch U-100	Insulin Degludec	19	suppressed
Trulicity	Dulaglutide	19	suppressed
Celecoxib	Celecoxib	17	suppressed
Hydrocortisone	Hydrocortisone	17	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	14
Pregabalin	Pregabalin	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Methimazole	Methimazole	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	15
Glipizide	Glipizide	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Azithromycin	Azithromycin	14	14
Bisoprolol Fumarate	Bisoprolol Fumarate	14	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	14	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Spiriva Handihaler	Tiotropium Bromide	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	13	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	13	suppressed
Nystatin	Nystatin	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error